Methyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate

Catalog No. :
ACTSHC843
CAS No. :
876316-95-9
Molecular Formula :
C10H10N2O2S
Molecular Weight :
222.27

IUPAC Name:methyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate

Methyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$176.00Login to see priceIn stockInquiry
250mg95%$255.00Login to see priceIn stockInquiry
1g95%$679.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate
IUPAC Namemethyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate
MDL No.MFCD30006229
Molecular FormulaC10H10N2O2S
Molecular Weight222.27
SMILESCN1C(C(OC)=O)=CC(C2=CC=CS2)=N1
InChI KeyPVRVZBPZLZYXCP-UHFFFAOYSA-N
SynonymMethyl 1-methyl-3-(thiophen-2-yl)-1H-pyrazole-5-carboxylate;1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(2-thienyl)-, methyl ester;methyl 2-methyl-5-(2-thienyl)pyrazole-3-carboxylate
CAS No.876316-95-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTSHC843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTPVA569 route compound structure diagram
    ACTPVA56957409-51-5 In Stock
  4. Then
  5. ACTSHC843 route product structure diagram
    ACTSHC843876316-95-9 In Stock
Inquiry

2. ACTSHC843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSHC843 route product structure diagram
    ACTSHC843876316-95-9 In Stock
Inquiry

Comments (0)